These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 10395030)
1. Reversal by [D-Ala2,D-Leu5]enkephalin of the dopamine transporter loss caused by methamphetamine. Tsao LI; Cadet JL; Su TP Eur J Pharmacol; 1999 May; 372(3):R5-7. PubMed ID: 10395030 [TBL] [Abstract][Full Text] [Related]
2. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53. Hayashi T; Hirata H; Asanuma M; Ladenheim B; Tsao LI; Cadet JL; Su TP Synapse; 2001 Mar; 39(4):305-12. PubMed ID: 11169780 [TBL] [Abstract][Full Text] [Related]
3. Delta opioid peptide [D-Ala2,D-leu5]enkephalin blocks the long-term loss of dopamine transporters induced by multiple administrations of methamphetamine: involvement of opioid receptors and reactive oxygen species. Tsao LI; Ladenheim B; Andrews AM; Chiueh CC; Cadet JL; Su TP J Pharmacol Exp Ther; 1998 Oct; 287(1):322-31. PubMed ID: 9765353 [TBL] [Abstract][Full Text] [Related]
13. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey. Melega WP; Lacan G; Desalles AA; Phelps ME Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033 [TBL] [Abstract][Full Text] [Related]
15. Ontogeny of neurokinin-1 receptor mediation of methamphetamine neurotoxicity in the striatum of the mouse brain. Yu J; Allison S; Ibrahim D; Cadet JL; Angulo JA Ann N Y Acad Sci; 2002 Jun; 965():247-53. PubMed ID: 12105100 [TBL] [Abstract][Full Text] [Related]
16. Dose-response and duration effects of acute administrations of cocaine and GBR12909 on dopamine synthesis and transporter in the conscious monkey brain: PET studies combined with microdialysis. Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T Brain Res; 2000 Mar; 860(1-2):141-8. PubMed ID: 10727633 [TBL] [Abstract][Full Text] [Related]
17. Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: oxidative consequences? Hanson GR; Gibb JW; Metzger RR; Kokoshka JM; Fleckenstein AE Ann N Y Acad Sci; 1998 May; 844():103-7. PubMed ID: 9668668 [TBL] [Abstract][Full Text] [Related]
18. Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters. Scheffel U; Steinert C; Kim SE; Ehlers MD; Boja JW; Kuhar MJ Synapse; 1996 Jun; 23(2):61-9. PubMed ID: 8723710 [TBL] [Abstract][Full Text] [Related]
19. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. Frey K; Kilbourn M; Robinson T Eur J Pharmacol; 1997 Sep; 334(2-3):273-9. PubMed ID: 9369358 [TBL] [Abstract][Full Text] [Related]
20. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Volkow ND; Chang L; Wang GJ; Fowler JS; Leonido-Yee M; Franceschi D; Sedler MJ; Gatley SJ; Hitzemann R; Ding YS; Logan J; Wong C; Miller EN Am J Psychiatry; 2001 Mar; 158(3):377-82. PubMed ID: 11229977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]